Company
United States3D Imaging Drug Design and Development, Little Rock, AR – FDA Inspections
Inspection records and compliance data for 3D Imaging Drug Design and Development in Little Rock, Arkansas. 4 FDA inspections on record (2 OAI), 3 Form 483s, 1 warning letter, last inspected June 13, 2025.
Company Profile
This profile covers 3D Imaging Drug Design and Development based in Little Rock, Arkansas, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 2
- VAI
- 2
- NAI
- 0
- Form 483s
- 3
- Warning letters
- 1
First inspected April 20, 2017. Last inspected June 13, 2025.
Most cited issue areas
- Adequate controls (general)3 inspections
- Analytical methods2 inspections
- Determination need for investigation2 inspections
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 13, 2025 | OAI | Human Drugs · Drug Quality Assurance | 1272748 |
| January 31, 2024 | VAI | Human Drugs · Bioresearch Monitoring | 1228168 |
| January 18, 2019 | VAI | Human Drugs · Generic Drug Evaluation | 1076821 |
| April 20, 2017 | OAI | Human Drugs · Drug Quality Assurance | 1009371 |
FDA documents
Warning Letters (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
3D Imaging Drug Design and Development
FEI Number
3009143510
Address
9015 Carti Way, Little Rock, Arkansas 72205, United States
Country
United States
ID: 52a34c85-0fab-4e15-8980-ba031bb418ce